Company news
Kexing Biopharm Co., Ltd. Class A (SSE:688136) news
Every Kexing Biopharm Co., Ltd. Class A press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 2
Kexing Biopharm Makes Its Debut at CPHI 2025, Followed by the 2025 International Pharmaceutical Cooperation High-End Forum, One of the Kexing Biopharm's Series of Globalization Activities in Shanghai
July 4, 2025
Announcement on Abnormal Fluctuations in Stock Trading
July 3, 2025
Announcement on the Progress of Proposed Transfer of Equity of Wholly-owned Subsidiary
July 2, 2025
Indicative Announcement on Change in Shareholder and Persons Acting in Concert's Equity Reaching an Integer Multiple of 5%
June 30, 2025
Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA
May 27, 2025